Maestro being used in a procedure. Image credit: Moon Surgical.

Surgeons in the US have used Moon Surgical’s Maestro system to aid weight loss surgery procedures, in what are the first-use cases of the robotic system in the country.

Maestro, which received US Food and Drug Administration (FDA) clearance in December 2022, is designed to assist in traditional laparoscopic procedures.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Three surgeons at Baptist Health in Florida, US, used the robotic system to help perform sleeve gastrectomies – the most common weight loss surgery. The robotic arms can hold and adjust instruments, reducing the number of staff required in the operating room.

Dr Ron Landmann, chief of colon and rectal surgery and medical director of informatics at Baptist Health said in a statement: “Maestro provides the control and dependability needed in minimally invasive surgery at a time when staffing shortages introduce workflow challenges and variability.”

Moon Surgical recently announced an updated version of the system received CE marking. Moon Surgical said it improved scalability and refined aesthetics, with additional features such as cloud connectivity and surgeon-guided hands-free scope control.

Anne Osdoit, CEO of Moon Surgical said in a statement: “After treating fifty patients in our first-in-human clinical trial, we are excited to be doing clinical cases in the US.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The robotics industry is growing at a CAGR of 29% and will be worth $568bn by 2030, according to GlobalData. In 2021, GlobalData valued the surgical robotics market at $9.6bn.

Earlier in September, UK robotic surgery group CMR Surgical raised $165m. In May 2023, Moon Surgical raised $55.4m in venture funding.